Vienna, Austria - One of the largest studies to date looking at the impact of stent thrombosis and its treatment suggests that once thrombosis occurs, it matters very little whether the culprit was a ...

Complete revascularization via staged PCI is linked to better 5-year outcomes compared with culprit-only PCI in STEMI patients with multivessel disease, according to new research out of China. Results ...

In patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI), stenting demonstrated improved long-term survival and fewer cardiac arrests at one year. The ...

Less than 50% of all patients with ST segment elevation myocardial infarction (STEMI) achieve both optimal reopening of the infarct-related artery and effective myocardial reperfusion, due to the ...

Patients who undergo percutaneous coronary intervention (PCI) to treat in-stent restenosis experience fewer major adverse events at 2 years if they remain on dual antiplatelet therapy (DAPT) for 24 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio In patients with high bleeding risk who ...

Patients with STEMI undergoing PCI and stenting showed no benefit from postconditioning in an MRI-based single-center study sponsored by the NHLBI, the Minneapolis Heart Institute Foundation announced ...

In patients with three-vessel and/or left main coronary artery disease (CAD), percutaneous coronary intervention (PCI) with paclitaxel-eluting stents is equivalent to coronary artery bypass grafting ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window For percutaneous ...

Although sometimes not technically possible, complete anatomic revascularization should be the goal of all coronary revascularization procedures, in combination with aggressive secondary prevention To ...

Editor’s note: This post is part of a Health Affairs Blog series titled “ORBITA: Lessons From A Landmark Trial," which focuses on the recent study finding that coronary stenting did not improve ...